Gujarat Themis Biosyn Balance Sheet Annual

Trade

BSE: 506879 | NSE: - | ISIN: INE942C01045 | Sector: Biotechnology & Drugs

326.00 +14.05 (4.50%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash	6.47	6.06	11.89	23.66
Cash Equivalents	1.69	0.03	0.46	3.97
Short Term Investments	8.18	3.75	11.48	14.61
Cashand Short Term Investments	16.34	9.83	23.83	42.25
Accounts Receivable- Trade Net	27.03	17.91	25.12	14.71
Total Receivables Net	27.03	35.53	42.64	14.73
Total Inventory	3.33	14.62	11.61	6.05
Other Current Assets Total	0.87	0.40	0.31	0.29
Total Current Assets	47.56	60.85	78.39	63.32
Property/ Plant/ Equipment Total- Net	129.24	53.26	32.13	21.02
Long Term Investments	34.39	-	9.21	1.30
Note Receivable- Long Term	0.75	51.48	-	-
Other Long Term Assets Total	9.17	0.75	2.78	2.62
Total Assets	221.11	166.33	122.50	88.26
Accounts Payable	9.91	9.54	6.62	3.54
Notes Payable/ Short Term Debt	0.00	0.00	0.00	0.00
Current Portof LT Debt/ Capital Leases	1.54	0.42	0.75	3.83
Other Currentliabilities Total	4.71	5.31	9.79	8.46
Total Current Liabilities	16.16	15.28	17.16	15.82
Long Term Debt	0.00	0.00	0.00	0.00
Capital Lease Obligations	1.22	0.00	0.42	1.00
Total Long Term Debt	1.22	0.00	0.42	1.00
Total Debt	2.77	0.42	1.17	4.83
Deferred Income Tax	1.66	1.30	1.02	0.98
Other Liabilities Total	0.69	0.60	0.58	0.51
Total Liabilities	19.74	17.18	19.18	18.32
Common Stock Total	7.26	7.26	7.26	7.26
Retained Earnings( Accumulated Deficit)	194.11	139.72	96.06	62.68
Other Equity Total	0.00	-	-	-
Total Equity	201.38	149.15	103.32	69.95
Total Liabilities Shareholders' Equity	221.11	166.33	122.50	88.26
Total Common Shares Outstanding	7.26	7.26	7.26	7.26
Tangible Book Valueper Share Common Eq	27.72	20.53	14.22	9.63
Prepaid Expenses	-	0.47	-	-
Property/ Plant/ Equipment Total- Gross	-	64.64	12.70	2.07
Accumulated Depreciation Total	-	-11.38	-	-
Additional Paid- In Capital	-	2.16	-	-